Phaarmaa One (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 04-12-2024
- Paid Up Capital ₹ 3.56 M
as on 04-12-2024
- Company Age 13 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.77 M
as on 04-12-2024
- Revenue 15.79%
(FY 2021)
- Profit 1299.82%
(FY 2021)
- Ebitda 613.83%
(FY 2021)
- Net Worth 446.77%
(FY 2021)
- Total Assets 15.78%
(FY 2021)
About Phaarmaa One (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.56 M.
The company currently has active open charges totaling ₹1.77 M.
Senthilnathan Rajagopal, Arun Senthilnathan, and Bhanu Dasari serve as directors at the Company.
- CIN/LLPIN
U52311TZ2012PTC017750
- Company No.
017750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Phaarmaa One (India) Private Limited offer?
Phaarmaa One (India) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Phaarmaa One (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilnathan Rajagopal  | Managing Director | 04-Jan-2012 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Senthilnathan | Director | 30-Sep-2023 | Current |
| Bhanu Dasari | Director | 12-Mar-2021 | Current |
Financial Performance of Phaarmaa One (India).
Phaarmaa One (India) Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 15.79% increase. The company also saw a substantial improvement in profitability, with a 1299.82% increase in profit. The company's net worth Soared by an impressive increase of 446.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phaarmaa One (India)?
In 2021, Phaarmaa One (India) had a promoter holding of 57.58% and a public holding of 42.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fastpill Healthcare Private LimitedActive 3 years 29 daysSenthilnathan Rajagopal and Arun Senthilnathan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 26 Apr 2017 | ₹1.77 M | Open |
How Many Employees Work at Phaarmaa One (India)?
Phaarmaa One (India) has a workforce of 9 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phaarmaa One (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phaarmaa One (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
